Randomised study of immunotherapy with OK-432 in uterine cervical carcinoma-Reference-Cited by-同舟云学术

Randomised study of immunotherapy with OK-432 in uterine cervical carcinoma

Published:1993-01 Issue:11 Volume:29 Page:1542-1546
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kikkawa Fumitaka,Hawai Michiyasu,Oguchi Hidenori,Kojima Masayoshi,Ishikawa Hisatake,Iwata Mitsumasa,Maeda Osamu,Tomoda Yutaka,Arii Yoshitaro,Kuzuya Kazuo,Ohta Masahiro,Ishizuka Takao,Hattori Sen-Ei,Aoki Kunio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Statement for the year 1980, inclusive, cervix;Kiichiro;Jpn J Obstet Gynecol,1988

2. Clinical studies with adjuvant surgery and irradiation therapy in the treatment of carcinoma of the cervix;Rutledge;Cancer,1976

3. Determination of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix;Fuller;Gynecol Oncol,1989

4. Radical pelvic surgery versus radiation therapy for stage 1 carcinoma of the cervix (exclusive of microinvasion);Morley;Obstet Gynecol,1976

5. Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells;Nio;Cancer,1989

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development;Cells;2024-01-02

2. E3 ubiquitin ligase BCA2 promotes breast cancer stemness by up-regulation of SOX9 by LPS;International Journal of Biological Sciences;2024

3. Preliminary Exploration of a New Therapy for Interstitial Cystitis/Bladder Pain Syndrome: Botulinum Toxin A Combined with Sapylin;Toxins;2022-11-30

4. Efficacy and Safety of Immunotherapy for Cervical Cancer—A Systematic Review of Clinical Trials;Cancers;2022-01-17

5. LPS/TLR4 pathways in breast cancer: insights into cell signalling;Current Medicinal Chemistry;2021-08-11